Paradoxical response with increased tumor necrosis factor-&#945; levels to anti-tuberculosis treatment in a patient with disseminated tuberculosis.

Watanabe, Sho; Kaneko, Yugo; Kawamoto, Hironori; Maehara, Tomoki; Baba, Yuri; Fujisaki, Ikumi; Saito, Nayuta; Ryu, Kai; Seki, Aya; Horikiri, Tsugumi; Kinoshita, Akira; Takeda, Hiroshi; Saito, Keisuke; Kuwano, Kazuyosi

Paradoxical response with increased tumor necrosis factor-α levels to anti-tuberculosis treatment in a patient with disseminated tuberculosis.

Watanabe, Sho; Kaneko, Yugo; Kawamoto, Hironori; Maehara, Tomoki; Baba, Yuri; Fujisaki, Ikumi; Saito, Nayuta; Ryu, Kai; Seki, Aya; Horikiri, Tsugumi; Kinoshita, Akira; Takeda, Hiroshi; Saito, Keisuke; Kuwano, Kazuyosi.

Afiliación

Watanabe S; Division of Respiratory Medicine, Department of Internal Medicine, Jikei Daisan Hospital, 11-1, Izumihoncho 4, Komae City, Tokyo, Japan.
Kaneko Y; Division of Respiratory Medicine, Department of Internal Medicine, Jikei Daisan Hospital, 11-1, Izumihoncho 4, Komae City, Tokyo, Japan.
Kawamoto H; Division of Respiratory Medicine, Department of Internal Medicine, Jikei Daisan Hospital, 11-1, Izumihoncho 4, Komae City, Tokyo, Japan.
Maehara T; Division of Respiratory Medicine, Department of Internal Medicine, Jikei Daisan Hospital, 11-1, Izumihoncho 4, Komae City, Tokyo, Japan.
Baba Y; Division of Respiratory Medicine, Department of Internal Medicine, Jikei Daisan Hospital, 11-1, Izumihoncho 4, Komae City, Tokyo, Japan.
Fujisaki I; Division of Respiratory Medicine, Department of Internal Medicine, Jikei Daisan Hospital, 11-1, Izumihoncho 4, Komae City, Tokyo, Japan.
Saito N; Division of Respiratory Medicine, Department of Internal Medicine, Jikei Daisan Hospital, 11-1, Izumihoncho 4, Komae City, Tokyo, Japan.
Ryu K; Division of Respiratory Medicine, Department of Internal Medicine, Jikei Daisan Hospital, 11-1, Izumihoncho 4, Komae City, Tokyo, Japan.
Seki A; Division of Respiratory Medicine, Department of Internal Medicine, Jikei Daisan Hospital, 11-1, Izumihoncho 4, Komae City, Tokyo, Japan.
Horikiri T; Division of Respiratory Medicine, Department of Internal Medicine, Jikei Daisan Hospital, 11-1, Izumihoncho 4, Komae City, Tokyo, Japan.
Kinoshita A; Division of Respiratory Medicine, Department of Internal Medicine, Jikei Daisan Hospital, 11-1, Izumihoncho 4, Komae City, Tokyo, Japan.
Takeda H; Division of Respiratory Medicine, Department of Internal Medicine, Jikei Daisan Hospital, 11-1, Izumihoncho 4, Komae City, Tokyo, Japan.
Saito K; Division of Respiratory Medicine, Department of Internal Medicine, Jikei Daisan Hospital, 11-1, Izumihoncho 4, Komae City, Tokyo, Japan.
Kuwano K; Department of Respiratory Medicine, Jikei University School of Medicine, 19-18, Nishishinbashi 3, Minato-ku, Tokyo, Japan.

Respir Med Case Rep ; 20: 201-204, 2017.

Article en En | MEDLINE | ID: mdl-28331797

Palabras clave

Adalimumab; ELISA, enzyme-linked immunosorbent assay; HRCT, high resolution computer tomography; IGRA, Interferon gamma release assay; IRIS, immune reconstruction syndrome; Immune reconstitution inflammatory syndrome; PR, Paradoxical response; Paradoxical response; TB, tuberculosis; TNF-α inhibitor; TNFα, Tumor necrosis factor alpha; Tuberculosis; Tumor necrosis factor alpha

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Respir Med Case Rep Año: 2017 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google